Offloading—the redistribution of mechanical pressure away from a wound—is one of the most powerful and yet most underused tools in diabetic foot care. Repetitive pressure on an insensate, neuropathic foot is a primary driver of plantar ulceration, and no dressing or advanced wound therapy can fully compensate for a wound that continues to bear weight with every step. Understanding how offloading works, and which devices the evidence supports, is central to healing diabetic foot ulcers and preventing their recurrence.
Why Pressure Relief Matters
In diabetes, peripheral neuropathy blunts the protective sensation that normally warns a person to shift their weight or stop walking when tissue is being damaged. Combined with foot deformity and altered gait, this produces zones of abnormally high plantar pressure. Left unrelieved, these pressures perpetuate tissue breakdown and delay closure of existing ulcers. The therapeutic principle is straightforward: reduce the load on the wound and the body’s own healing processes can proceed. The clinical challenge is achieving that pressure relief reliably, in a way patients can tolerate day to day.
The Evidence for Non-Removable Devices
Across systematic reviews and meta-analyses, non-removable knee-high devices consistently emerge as the most effective form of offloading. The total contact cast (TCC)—a close-fitting cast that distributes pressure across the entire plantar surface and lower leg—is widely regarded as the gold standard. A 2023 systematic review of randomized and controlled trials involving 822 patients concluded that the total contact cast was the most effective offloading method available, despite its recognized drawbacks (Velasco-Rodríguez-Rabadán et al., 2023).
A key reason non-removable devices outperform removable ones is adherence. A device the patient cannot take off is worn during every step, whereas removable walkers are frequently removed at home. A 2022 rapid review with meta-analysis and trial sequential analysis found that non-removable fiberglass total contact casting shortened healing time by roughly five days compared with removable cast walkers—a finding the trial sequential analysis supported as robust (Okoli et al., 2022). The magnitude is modest, but it reflects a consistent direction of benefit across trials.
A 2024 meta-analysis of 18 randomized controlled trials, conducted to inform the Italian guidelines on diabetic foot syndrome, reinforced and extended these conclusions. Any plantar offloading device was associated with significantly higher ulcer healing rates than no device at all (odds ratio 3.13), and total contact casts or non-removable knee-high walkers healed ulcers more often than other offloading devices (odds ratio 2.64). The analysis also found that surgical offloading of an active ulcer, combined with post-operative offloading, produced higher healing rates than offloading devices alone in selected cases (Gauna et al., 2024).
What the Guidelines Recommend
The International Working Group on the Diabetic Foot (IWGDF) issued an updated evidence-based offloading guideline in 2023. It recommends a non-removable knee-high offloading device—a total contact cast or a non-removable knee-high walker—as the first-choice treatment for a neuropathic plantar forefoot or midfoot ulcer. When a non-removable device is contraindicated or not tolerated, a removable knee-high device is preferred over an ankle-high one, with clear counseling that the device must be worn consistently. Conventional or standard footwear is explicitly not recommended for healing these ulcers (Bus et al., 2024). The guideline also addresses adjuncts such as offloading footwear for remission and surgical options for wounds that fail to respond.
Special Considerations and Practical Barriers
Offloading is not one-size-fits-all. Wound location, infection, ischemia, foot deformity, balance, and patient occupation all shape the choice of device. In active Charcot neuro-osteoarthropathy, total contact casting remains the accepted standard for the acute phase; a 2024 systematic review found limited evidence to support routine non-weight-bearing during casting, noting that permitting weight-bearing did not appear to harm healing and offered advantages for independence and quality of life—though the authors called for randomized trials to settle the question (Prem et al., 2024).
Despite strong evidence, the total contact cast remains underused in everyday practice. Barriers include the time and skill required to apply it correctly, concerns about cast-related (iatrogenic) skin injury, patient discomfort, and difficulties with bathing, sleeping, and walking. These practical realities help explain why clinicians often default to removable devices, and why patient education and careful device selection matter as much as the device itself.
Key Takeaways
The evidence points in a consistent direction: effective pressure relief is essential to healing diabetic foot ulcers, and non-removable knee-high devices—led by the total contact cast—are the most effective option for neuropathic plantar wounds. Removable devices can work, but their success depends heavily on being worn as directed. Standard footwear is inadequate for healing an active ulcer. Because offloading must be matched to the individual wound, foot structure, and circulation, device selection is a clinical decision that balances biomechanical effectiveness against tolerability and safety.
References
Bus SA, Armstrong DG, Crews RT, et al. Guidelines on offloading foot ulcers in persons with diabetes (IWGDF 2023 update). Diabetes/Metabolism Research and Reviews. 2024;40(3):e3647.
Gauna C, Romeo F, Scatena A, et al. Offloading systems for the treatment of neuropathic foot ulcers in patients with diabetes mellitus: a meta-analysis of randomized controlled trials for the development of the Italian guidelines for the treatment of diabetic foot syndrome. Acta Diabetologica. 2024;61(6):693–703.
Okoli GN, Rabbani R, Lam OLT, et al. Offloading devices for neuropathic foot ulcers in adult persons with type 1 or type 2 diabetes: a rapid review with meta-analysis and trial sequential analysis of randomized controlled trials. BMJ Open Diabetes Research & Care. 2022;10(3):e002822.
Velasco-Rodríguez-Rabadán S, Tardáguila-García A, Sanz-Corbalán I, et al. Effectiveness of off-loading devices in patients with active diabetic foot ulcer: a systematic review. The International Journal of Lower Extremity Wounds. 2023;24(4):887–893.
Prem R, Vignaraja V, Lewis T, Budair B. Weight bearing versus non-weight bearing total contact cast in the management of active Charcot foot: a systematic review. SAGE Open Medicine. 2024;12:20503121241306957.
Comments
